Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Minoxidil and finasteride treat hair loss; more research needed for other options.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Neurosteroids show promise for treating epilepsy and more research is needed.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

SHBG may be a useful early indicator and treatment target for PCOS.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

New alopecia treatments aim for better results and fewer side effects.

Mutations in the spike protein affect drug binding and effectiveness.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.